During the past decade, Cascade Cancer Center at Evergreen Hospital Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 20 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cascade Cancer Center at Evergreen Hospital Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 9 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cascade Cancer Center at Evergreen Hospital Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Cascade Cancer Center at Evergreen Hospital Medical Center" are "Breast Cancer" (14 trials), "Lung Cancer" (5 trials), "Prostate Cancer" (4 trials), "Fatigue" (3 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (3 trials). Many other conditions were trialed in "Cascade Cancer Center at Evergreen Hospital Medical Center" in a lesser frequency.

Most popular intervention types in "Cascade Cancer Center at Evergreen Hospital Medical Center" are "Drug" (29 trials), "Other" (12 trials), "Procedure" (6 trials), "Radiation" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (10 trials), "docetaxel" (4 trials), "Paclitaxel" (2 trials), "Vatalanib" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cascade Cancer Center at Evergreen Hospital Medical Center" are 21 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Cascade Cancer Center at Evergreen Hospital Medical Center". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Cascade Cancer Center at Evergreen Hospital Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cascade Cancer Center at Evergreen Hospital Medical Center, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".